Vaccines
Australia's vaccine rollout plan has been clouded by the European Union's decision to impose export controls on COVID-19 vaccines, including those produced in Europe by Pfizer and AstraZeneca. The Morrison government's vaccination plan relies heavily on imports, including 10 million doses of the Pfizer
Vaccines
As high-income countries rapidly implement COVID-19 vaccination programs, the challenges facing low- and middle-income nations are becoming increasingly apparent. Widespread vaccination, crucial for halting the pandemic, may be years away for many nations, due in part to logistical issues and limited access to existing vaccines. In response, middle-income countries are
Vaccines
Indian conglomerates are preparing to secure COVID-19 vaccines for their employees once government approvals are in place, with top officials stating that companies are ready to absorb the vaccination costs. The Confederation of Indian Industry (CII) has set up a 25-member task force to fast-track the inoculation drive for private
Vaccines
The European Union has begun the approval process for its third vaccine against the coronavirus, despite the World Health Organization warning that achieving herd immunity this year is unlikely, even with mass inoculation schemes. The 27-member EU has promised an accelerated timeline after confirming that drug company AstraZeneca had applied
Vaccines
Johnson & Johnson's one-dose COVID-19 vaccine regimen is poised to play a crucial role in expanding vaccine access in the US and beyond, despite the faltering immunization push. The pharmaceutical giant is in the final stages of data analysis for its phase 3 trial, with CEO Alex Gorsky
Vaccines
The COVID-19 pandemic has highlighted the complexities of vaccine distribution, particularly the challenge of maintaining ultra-cold temperatures required for mRNA vaccines developed by Pfizer/BioNTech and Moderna. These vaccines must be stored at temperatures below -112 F (-80 C) and -4 F (-20 C) respectively, which is a significant logistical
Vaccines
Pfizer Inc. and BioNTech SE have announced plans to supply an additional 100 million doses of the COVID-19 vaccine, COMIRNATY, to the European Union (EU) in 2021. This decision comes as a result of the European Commission's exercise of its option to purchase an additional 100 million doses
Vaccines
As regulators in Asia consider approval for COVID-19 vaccines developed by various pharmaceutical companies, details of estimated distribution timelines, announced supply deals, and clinical trials in the region are emerging. Singapore has become the first country to begin inoculation, with advanced purchase pacts and early down-payments on vaccines from Pfizer,
Vaccines
The Texas Department of State Health Services has issued an instruction to the Centers for Disease Control and Prevention to ship COVID-19 vaccine to over 350 providers in 94 Texas counties. This expansion aims to reach more than 300 long-term-care facilities, serving staff and residents in the first week. The
Vaccines
In a year marked by the COVID-19 pandemic, the winter holidays have brought a season of hope with the emergence of two COVID-19 vaccines. The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to vaccines from Pfizer/BioNTech and Moderna, enabling distribution to high-risk groups. These
Vaccines
Mentor Capital, a company known for financially supporting leading-edge immunotherapies in the fight against cancer, has expanded its portfolio to include vaccine manufacturers and associated medical companies involved in the fight against SARS-CoV-2. The company's initial investments are in Pfizer, Moderna, BioNTech, and AstraZeneca, with a focus on
Vaccines
As the State of Maryland embarks on its COVID-19 vaccination plan, the first five University of Maryland Medical System (UMMS) frontline healthcare workers have received the Pfizer COVID-19 vaccine. In a historic undertaking, Governor Larry Hogan thanked these brave individuals for agreeing to be the first recipients of the vaccine.
